We are live on ! Find out more
CVS icon

CVS Health

1,972 hedge funds and large institutions have $68.1B invested in CVS Health in 2020 Q4 according to their latest regulatory filings, with 277 funds opening new positions, 842 increasing their positions, 720 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

195% more first-time investments, than exits

New positions opened: 277 | Existing positions closed: 94

38% more call options, than puts

Call options by funds: $1.88B | Put options by funds: $1.36B

30% more funds holding in top 10

Funds holding in top 10: 4660 (+14)

17% more capital invested

Capital invested by funds: $58.2B → $68.1B (+$9.97B)

17% more repeat investments, than reductions

Existing positions increased: 842 | Existing positions reduced: 720

9% more funds holding

Funds holding: 1,8151,972 (+157)

0.1% less ownership

Funds ownership: 76.22%76.12% (-0.1%)

Holders
1,972
Holders Change
+157
Holders Change %
+8.65%
% of All Funds
34.9%
Holding in Top 10
60
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+30.43%
% of All Funds
1.06%
New
277
Increased
842
Reduced
720
Closed
94
Calls
$1.88B
Puts
$1.36B
Net Calls
+$523M
Net Calls Change
-$123M
Name Holding Trade Value Shares
Change
Change in
Stake
BCM
401
Buckhead Capital Management
Georgia
$9.44M -$610K -9,372 -6%
Cetera Investment Advisers
402
Cetera Investment Advisers
Illinois
$9.42M +$6.94M +106,653 +341%
BFS
403
Bard Financial Services
Connecticut
$9.16M +$8.72M +134,108 New
Kovitz Investment Group Partners
404
Kovitz Investment Group Partners
Illinois
$9.1M +$882K +13,565 +11%
DA
405
DSC Advisors
Illinois
$9.04M -$17.3K -266 -0.2%
SIC
406
Salem Investment Counselors
North Carolina
$8.97M -$169K -2,595 -2%
BRA
407
Biechele Royce Advisors
Indiana
$8.96M +$189K +2,907 +2%
SAM
408
Stansberry Asset Management
Texas
$8.9M +$195K +2,998 +2%
ECM
409
Evergreen Capital Management
Washington
$8.9M +$8.1M +124,478 +2,127%
IIM
410
Intact Investment Management
Quebec, Canada
$8.9M -$1.22M -18,800 -13%
TW
411
TrinityPoint Wealth
Connecticut
$8.88M +$1.44M +22,157 +23%
CCM
412
Campbell Capital Management
Florida
$8.88M +$111K +1,700 +1%
WF
413
Welch & Forbes
Massachusetts
$8.68M -$26.1K -401 -0.3%
WT
414
Whittier Trust
California
$8.67M +$262K +4,028 +3%
MC
415
Miramar Capital
Illinois
$8.67M +$1.39M +21,340 +22%
WCMN
416
Westchester Capital Management (Nebraska)
Nebraska
$8.67M +$133K +2,047 +2%
MHC
417
Meyer Handelman Company
New York
$8.64M +$444K +6,833 +6%
LOPW
418
Live Oak Private Wealth
North Carolina
$8.63M +$356K +5,480 +5%
FLPIM
419
F.L. Putnam Investment Management
Massachusetts
$8.62M +$920K +14,152 +13%
II
420
IFM Investors
Australia
$8.6M +$1.21M +18,531 +17%
Wolverine Trading
421
Wolverine Trading
Illinois
$8.58M +$131K +2,008 +2%
CIA
422
Capital Investment Advisors
Georgia
$8.4M +$1.09M +16,793 +16%
SFI
423
Siemens Fonds Invest
Germany
$8.39M +$8.06M +123,858 New
GI
424
Gradient Investments
Minnesota
$8.35M -$134K -2,061 -1%
PIM
425
Perpetual Investment Management
Australia
$8.35M +$8.02M +123,296 New

CVS Hedge Fund Activity: Q4 2020 in Review

1,972 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q4 2020, worth a combined $68.1B — up 17% from $58.2B a quarter earlier.

Buyers outnumbered sellers: 277 funds opened new CVS positions and 94 closed out — a net gain of 183 holders — while 842 added to existing stakes and 720 trimmed.

The largest buyer was Capital International Investors, adding an estimated $272M. The largest seller was BlackRock, cutting an estimated $508M.

  • 1,972 institutional investors held CVS Health (CVS) as of Q4 2020, up from 1,815 in Q3 2020.
  • Funds reported $68.1B of CVS Health stock for Q4 2020, up 17% quarter-over-quarter.
  • 277 funds opened new CVS Health positions in Q4 2020 and 94 closed out, a net change of +183 holders.
  • The largest CVS Health buyer in Q4 2020 was Capital International Investors, an estimated $272M added.
  • The largest CVS Health seller in Q4 2020 was BlackRock, an estimated $508M sold.

Based on aggregated 13F filings for Q4 2020.